In last trading session, Bright Minds Biosciences Inc (NASDAQ:DRUG) saw 0.3 million shares changing hands with its beta currently measuring -6.93. Company’s recent per share price level of $46.62 trading at -$1.9 or -3.92% at ring of the bell on the day assigns it a market valuation of $391.61M. That closing price of DRUG’s stock is at a discount of -69.5% from its 52-week high price of $79.02 and is indicating a premium of 98.01% from its 52-week low price of $0.93. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.57 million shares which gives us an average trading volume of 2.98 million if we extend that period to 3-months.
Bright Minds Biosciences Inc (NASDAQ:DRUG) trade information
Upright in the red during last session for losing -3.92%, in the last five days DRUG remained trading in the red while hitting it’s week-highest on Wednesday, 11/06/24 when the stock touched $46.62 price level, adding 19.62% to its value on the day. Bright Minds Biosciences Inc’s shares saw a change of 3160.14% in year-to-date performance and have moved -3.24% in past 5-day. Bright Minds Biosciences Inc (NASDAQ:DRUG) showed a performance of 4257.01% in past 30-days. Number of shares sold short was 1.17 million shares which calculate 0.21 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -137.36% during past 5 years.
Bright Minds Biosciences Inc (NASDAQ:DRUG)’s Major holders
Insiders are in possession of 24.58% of company’s total shares while institution are holding 34.72 percent of that, with stock having share float percentage of 46.03%. Investors also watch the number of corporate investors in a company very closely, which is 34.72% institutions for Bright Minds Biosciences Inc that are currently holding shares of the company.
